Teva Pharm raises 2018 profit outlook, sees strong migraine drug launch | Reuters
Corcept Therapeutics plunges amid patent trial with Teva (NASDAQ:CORT) | Seeking Alpha
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
Teva Eyes 25 Percent of the $750 Million EpiPen Market by Year's End | BioSpace
Teva Pharmaceuticals Successfully Defends Against Allegations of Patent Infringement | Parsippany Focus
Teva agrees to pay $126 million to US hospitals over opioids | Reuters
Israel's Teva to move US HQ from Pennsylvania to New Jersey | The Times of Israel
Teva Pharmaceutical reports Q1 2018 | AlphaStreet
FDA approves Teva's generic EpiPen after yearslong delay
Teva Pharmaceutical revenue by region 2018-2023 | Statista
Governor Phil Murphy signed a Proclamation welcoming Teva … | Flickr
Teva ponies up $420M to settle with investors who said company hid price-fixing scheme | Fierce Pharma
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva Pharmaceuticals USA found liable in opioids case - Newsday
Teva Pharmaceutical Stock: Stuck In A Cycle Of Hope And Disappointment | Seeking Alpha
Teva, one of the biggest generic makers, joins the the brand-name club
Is Teva Pharmaceuticals a Brilliant Contrarian Pick? | The Motley Fool
Teva Pharmaceutical Statistics, Facts, Revenue, Subsidiaries
Teva (TEVA) to Cut Back Generic Drug Production Amid Shortages - Bloomberg
Teva Pharmaceuticals on X: "Teva unveils new world class #pharma facility at #Mumbai R&D center: https://t.co/s0LOWejMwH https://t.co/jKjOxoAaGc" / X
$40 million incentive lures global pharmaceutical giant to Parsippany
Teva shares surge after announcing global opioid settlement
Teva Will Pay Up to $126 Million to U.S. Hospitals Over Opioids - news.law
Teva down as it reports lower sales and profit for 2018
Teva Is the 23rd Drug Maker to Impose Limits on 340B Contract Pharmacies - 340B Report
